Massachusetts Wealth Management Has $1.03 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Massachusetts Wealth Management boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 19.4% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,221 shares of the company’s stock after buying an additional 2,150 shares during the period. Massachusetts Wealth Management’s holdings in GE HealthCare Technologies were worth $1,030,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of GEHC. Vanguard Group Inc. boosted its stake in GE HealthCare Technologies by 9.2% in the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after buying an additional 4,107,746 shares in the last quarter. Norges Bank bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at approximately $229,052,000. Capital Research Global Investors increased its position in GE HealthCare Technologies by 5.2% during the 1st quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock worth $4,908,406,000 after purchasing an additional 2,647,204 shares in the last quarter. Perpetual Ltd bought a new stake in GE HealthCare Technologies during the 1st quarter worth $96,135,000. Finally, Jacobs Levy Equity Management Inc. increased its position in GE HealthCare Technologies by 4,959.8% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 758,514 shares of the company’s stock valued at $68,957,000 after acquiring an additional 743,523 shares during the period. 82.06% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Stock Up 0.9 %

NASDAQ GEHC traded up $0.74 during trading on Friday, hitting $84.82. The company’s stock had a trading volume of 1,838,607 shares, compared to its average volume of 1,760,048. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. The company has a market cap of $38.73 billion, a PE ratio of 24.80, a P/E/G ratio of 3.17 and a beta of 1.17. The business’s 50 day simple moving average is $81.35 and its 200-day simple moving average is $83.49.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. During the same quarter in the previous year, the company posted $0.92 earnings per share. The company’s revenue was up .5% compared to the same quarter last year. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date of this dividend was Friday, July 19th. GE HealthCare Technologies’s payout ratio is 3.51%.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. The Goldman Sachs Group began coverage on shares of GE HealthCare Technologies in a report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price target on the stock. Finally, Stifel Nicolaus began coverage on GE HealthCare Technologies in a research note on Tuesday, August 6th. They issued a “buy” rating and a $100.00 target price on the stock. Five investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $95.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.